Epidermal growth factor receptor inhibition alleviates cardiac ischemia/reperfusion injury through preventing mitochondrial dysfunction and ferroptosis via Rho Family GTPase 3/5′ AMP-activated protein kinase axis
Epidermal growth factor receptor inhibition alleviates cardiac ischemia/reperfusion injury through preventing mitochondrial dysfunction and ferroptosis via Rho Family GTPase 3/5′ AMP-activated protein kinase axis. // Biochimica et Biophysica Acta: Molecular Basis of Disease. – URL: https://www.sciencedirect.com/science/article/pii/S0925443926003674?dgcid=rss_sd_all
Epidermal growth factor receptor inhibition alleviates cardiac ischemia/reperfusion injury through preventing mitochondrial dysfunction and ferroptosis via Rho Family GTPase 3/5′ AMP-activated protein kinase axis. Biochimica et Biophysica Acta: Molecular Basis of Disease. https://www.sciencedirect.com/science/article/pii/S0925443926003674?dgcid=rss_sd_all
“Epidermal growth factor receptor inhibition alleviates cardiac ischemia/reperfusion injury through preventing mitochondrial dysfunction and ferroptosis via Rho Family GTPase 3/5′ AMP-activated protein kinase axis.” Biochimica et Biophysica Acta: Molecular Basis of Disease.
@article{article37652,
title = {Epidermal growth factor receptor inhibition alleviates cardiac ischemia/reperfusion injury through preventing mitochondrial dysfunction and ferroptosis via Rho Family GTPase 3/5′ AMP-activated protein kinase axis},
journal = {Biochimica et Biophysica Acta: Molecular Basis of Disease},
url = {https://www.sciencedirect.com/science/article/pii/S0925443926003674?dgcid=rss_sd_all}
}